Construction of a Prognostic Nomogram Model for Patients with Mucinous Breast Cancer

Table 2

Results of univariate and multivariate analysis affecting the survival prognosis of 2776 patients in the modeling group.

Clinical pathology characteristics	Univariate analysis			Multivariate analysis
	Hr value	95% confidence interval	Value	HR value	95% confidence interval	Value
Age
18–39		1			1
40–59	0.92	0.32–2.66	0.892	0.75	0.26 to 2.19	0.604
60–79	1.73	0.63–4.71	0.285	1.61	0.57–4.52	0.368
≥80	7.67	2.83–20.81	<0.001	5.34	1.89–15.08	0.002
Ethnicity
White		1			1
Black	1.07	0.73 to 1.57	0.725	1.17	0.79–1.74	0.434
Others	0.39	0.22–0.70	0.001	0.48	0.26 to 0.87	0.015
Marital status
Married		1			1
Unmarried	2.10	1.60–2.77	<0.001	1.22	0.91 to 1.64	0.184
Lesion location
Left		1			1
Right	1.14	0.88–1.48	0.311	1.88	0.91 to 1.55	0.205
Histological grading
I		1			1
II	1.09	0.83–1.44	0.522	1.00	0.76–1.33	0.978
III	1.62	0.90–2.93	0.110	1.98	0.63–2.28	0.584
IV	4.79	0.67–34.29	0.119	2.29	0.30–17.59	0.427
T Stage
T1		1			1
T2	1.93	1.45–2.57	<0.001	1.69	1.25–2.30	<0.001
T3	2.53	1.58–4.04	<0.001	1.77	1.05–2.97	0.031
T4	9.72	5.88–16.07	<0.001	3.54	1.86–6.73	<0.001
N Stage
N0		1			1
N1	1.60	1.06–2.41	0.025	1.37	0.88–2.15	0.168
N2	2.13	0.87–5.18	0.095	2.16	0.84–5.56	0.111
N3	3.71	1.52–9.02	0.039	0.35	0.12–1.07	0.066
M Stage
M0		1			1
M1	12.10	7.69–19.05	<0.001	7.22	3.98–13.12	<0.001
ER expression
Negative		1			1
Positive	0.72	0.27–1.93	0.514	0.70	0.23–2.11	0.529
PR expression
Negative		1			1
Positive	0.68	0.45–1.02	0.065	0.77	0.49 to 1.21	0.257
HER-2 expression
Negative		1			1
Positive	0.56	0.28–1.23	0.105	1.02	0.48–2.19	0.956
Surgery
Yes		1			1
None	6.69	4.59–9.76	<0.001	1.96	1.22–3.13	0.005
Radiotherapy
Yes		1			1
None	2.86	2.15–3.82	<0.001	1.86	1.37–2.51	<0.001
Chemotherapy
Yes		1			1
None	1.79	1.12–2.86	0.015	1.41	0.78–2.55	0.250